U. S. Spending on Prescription Drugs Fell Slightly in 2012

March 2013
MondayMorning;3/25/2013, Vol. 21 Issue 11, p1
The article reports that the U.S. spending on prescription drugs has dropped down by one percent to 325.7 billion U.S. dollars in the year 2012. It mentions that the spending has been falling down for years as the use of low-cost generics has increased in the nation. It also presents the data released by the pharmacy benefit manager Express Scripts Inc. that shows the spending on pills used to treat high blood pressure and cholesterol has decreased by 1.5 percent.


Related Articles

  • PBMs are driving up generic utilization. Sipkoff, Martin // Drug Topics;8/8/2005 Supplement, p14s 

    This article discusses why generics are now the drug of choice of most pharmacy benefit managers (PBM) in the United States. PBM company Express Scripts Inc.'s generic utilization rate is the highest in the industry. Express Scripts' customers want it to use generics. The increasing use of...

  • NO-NAME GENERICS WITH BRAND-NAME PRICES. Shalo, Sibyl // Pharmaceutical Executive;Sep2001, Vol. 21 Issue 9, p114 

    Focuses on a report and analysis of generic drugs conducted by Express Scripts. Overview of the trend in the pricing and expiration of patents of generic drugs; Benefit of the trends on generics in antihistamine and antianxiety classes; Forecast on prescription rates for the classes of generics.

  • Medicalization of aging comes at a price. DAVIS, ANDREA // Employee Benefit News;Feb2013, Vol. 27 Issue 2, p20 

    The article offers information on the study conducted by pharmacy benefit manager Express Scripts Inc. which reveals that the costs of prescription medication which are being used for aging-related conditions have steadily increasing over five years ending 2013.

  • Drug Watch 2009.  // Public Employee Quarterly;Sep2009, p3 

    The article reports on the lower overall drug cost trend in 2009 in Canada as reported by ESI Canada. It relates that ESI sees a decline of 2.1% in overall drug cost trend in 2009 compared with 2008. It highlights the role of generic drugs in the decline in overall drug cost trend. ESI has found...

  • Riding the generics wave to drug savings. Gresham, Lynn // Employee Benefit News;Jun2006, Vol. 20 Issue 8, p9 

    Focuses on the opportunity of drug plan sponsors in the U.S. in the prospect of many drugs going off patent. Number of brand-name drugs that are expected to become available as generics during the next five years from 2006; Amount to be spent by U.S. consumers on prescription medication in 2006...

  • National challenge issued In dose the prescription access gap.  // Westchester County Business Journal;11/22/2004, Vol. 43 Issue 47, p31 

    Focuses on Rx Outreach, a drug-assistance program, for generic drugs designed to allow United States consumers to get more affordable medications. Development of the program by Express Scripts Specialty Distribution Services Inc as part of its mission to help make the use of prescription drugs...

  • EU Commission Fines Servier, Five Others $583 Million on Generic Drug Delays.  // MondayMorning;7/14/2014, Vol. 22 Issue 26, p1 

    The article discusses issues concerning sale of cheaper versions of perindopril drug, hypertension treatment drug, invented by the Les Laboratoires Servier SAS. It mentions that Servier paid money to generic-drug producers to stop the release of generic form of perindopril drug in the market,...

  • Generics, The Purple Pill Saga And OTC's.  // Health & Stress;2003, Issue 2, p3 

    Focuses on the failure of generic drugs to reduce rising drug costs in the United States. Efforts by Astra-Zeneca to block generic versions of the best-selling prescription drug, Prilosec, after its patent expired in October 2001; Schering-Plough's offer of free seven-day trials to switch...

  • Coalition to educate consumers, address generic Rx legislation. Popolillo, Melissa C. // Drug Store News;7/20/98, Vol. 20 Issue 11, pCP1 

    Focuses on the formation of the Coalition for Affordable Pharmaceuticals in the United States. Goal of promoting legislation that will improve consumer access to affordable generic pharmaceutical products; Online forum for visitors to learn about generics; Challenges brought upon by branded...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics